COMBINATION FORMULATIONS

Micronized tanaproget, compositions, and methods of preparing the same

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

TABLETED COMPOSITIONS CONTAINING ATAZANAVIR

Cellulose-based fine core particle and process for producing the same

Antiretroviral Solid Oral Composition

CONTROLLED RELEASE COMPOSITION AND PREPARATION THEREOF

SUSTAINED RELEASE FORMULATIONS OF DIVALPROEX SODIUM

Ibuprofen-Effervescent Preparation Having a High Dissolution Rate and Method for the Production thereof

MELT-EXTRUDED ORALLY ADMINISTRABLE OPIOID FORMULATIONS

SOLID COMPOSITES OF A CALCIUM RECEPTOR-ACTIVE COMPOUND

Eutectic-based self-nanoemulsified drug delivery system

Modified release formulations containing drug-ion exchange resin complexes

PHARMACEUTICAL DOSAGE FORMS AND METHODS OF MANUFACTURING SAME

Process for making compositions with poorly compressible therapeutic compounds

Tablet Having Improved Stability With At Least Two Actives

Method for producing pharmaceutical tablet

Solid orally administerable pharmaceutical dosage forms with rapid active principle release

Formulations for delivering insulin

EXTENDED RELEASE TABLET FORMULATION OF NIACIN

METHOD OF PREPARING SOLID DOSAGE FORMS OF MULTI-PHASIC PHARMACEUTICAL COMPOSITIONS

Solid preparation comprising alogliptin and metformin hydrochloride

Oral preparation comprising pioglitazone

CONTROLLED-RELEASE PREPARATION CONTAINING CILOSTAZOL AND PROCESS FOR THE PREPARATION THEREOF

PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL

Non-abusable pharmaceutical composition comprising opioids

NOVEL PHARMACEUTICAL COMPOSITION

Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate

STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM

Process for preparing oral calcium compositions

Tacrolimus for improved treatment of transplant patients

Compressed Chewing Gum Comprising An Encapsulation Delivery System Comprising Natural Resin

EXTENDED RELEASE ORAL ACETAMINOPHEN/TRAMADOL DOSAGE FORM

Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom

Method for preparing sustained release tablet

Levodopa prodrug mesylate hydrate

PROCESS OF PRODUCING DIRECTLY COMPRESSED TABLETS OF STEROLS AND/OR STANOLS

Micronized Eplerenone Compositions

PH SENSITIVE MATRIX FORMULATION

Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes

Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors

Stabilized Coating for Pharmaceutical Formulations

Method for making cetirizine tablets

MODIFIED RELEASE PHARMACEUTICAL COMPOSITION AND A PROCESS OF MAKING THE SAME

PHARMACEUTICAL FORMULATIONS CONTAINING MICROPARTICLES OR NANOPARTICLES OF A DELIVERY AGENT

3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY

Hot-melt extrusion of modified release multi-particulates

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)

PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS

METHOD OF TREATMENT FOR INFLAMMATORY BOWEL DISEASE

Pharmaceutical Formulation Comprising Metformin and Repaglinide

Methods and Compositions for the Treatment of CNS-Related Conditions

Octreotide implant having a release agent and uses thereof

Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus

ORALLY RAPID DISINTEGRATING TABLET PREPARATION COMPRISING FAT-SOLUBLE ACTIVE INGREDIENTS

METHOD OF PROTECTING SENSITIVE MOLECULES FROM A PHOTO-POLYMERIZING ENVIRONMENT

Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances

Solid dispersions comprising tacrolimus

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE

Use of solid carrier particles to improve the processability of a pharmaceutical agent

MODAFINIL FORMULATIONS

Controlled-release formulations, method of manufacture, and use thereof

Solid dosage form of coated bisphosphonate particles

Water-insoluble, iron-containing mixed metal, granular material

Pharmaceutical formulation

Combination preparations of o-acetylsalicylic acid salts

SOLID ORAL FORMS OF EBASTINE

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

PHARMACEUTICAL FORMULATION OF LOSARTAN

NANOPARTICULATE ANTICONVULSANT AND IMMUNOSUPPRESSIVE COMPOSITIONS

Stable Pharmaceutical Compositions Containing Pravastatin

Process for manufacturing chewable dosage forms for drug delivery and products thereof

PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL

CB-1 receptor modulator formulations

LEVETIRACETAM FORMULATIONS

TASTE-MASKED PHARMACEUTICAL COMPOSITIONS PREPARED BY COACERVATION

COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS

COMPOSITION AND METHOD FOR BINDING ACETALDEHYDE IN STOMACH

Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives

Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions

Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same

PHARMACEUTICAL COMPOSITIONS COMPRISING A TRIPTAN AND A NONSTEROIDAL ANTI-INFLAMMATORY DRUG

TABLET FORMULATION

GRANULAR PHARMACEUTICAL COMPOSITIONS

Pharmaceutical Compositions

EXTENDED RELEASE FORMULATION CONTAINING A WAX

PHARMACEUTICAL COMPOSITIONS COMPRISING CONJUGATED ESTROGENS

Compressed

Controlled release delivery device comprising an organosol coat

Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same

Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists

PHARMACEUTICAL FORMULATIONS COMPRISING IBUPROFEN AND DIPHENHYDRAMINE

Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor

Tranexamic acid formulations

Solid preparation

TABLETS COMPRISING CANDESARTAN CILEXETIL

Extended release dosage forms of metoprolol

NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR

Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor

Galenical formulations of organic compounds

FENOFIBRATE FORMULATIONS

Pharmaceutical composition

Controlled release hydrocodone formulations

Pharmaceutical composition of amlodipine maleate having enhanced stability

Pregelatinized starch in a controlled release formulation

NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR

Solid multilayer oral dosage forms

Form of administration of racecadotril

Controlled Release Solid Preparation

Misuse preventative, controlled release formulation

Fast release paracetamol tablets

ORALLY DISINTEGRATING TABLET COMPOSITIONS OF TEMAZEPAM

RALOXIFENE COMPOSITION

Pharmaceutical compositions

ORALLY DISINTEGRATING TABLETS COMPRISING DIPHENHYDRAMINE

GRANULATED PARTICLES, TABLETS AND METHOD FOR PRODUCING GRANULATED PARTICLES

Microemulsion containing indolocarbazole compound and dosage forms containing the same

Method of producing solid preparation disintegrating in the oral cavity

HEATED ROLLER COMPACTION PROCESS FOR MAKING PHARMACEUTICAL COMPOSITIONS

MELT-EXTRUSION MULTIPARTICULATES

NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING A DISINTEGRATION MATRIX

DEFERASIROX PHARMACEUTICAL COMPOSITIONS

Composition Comprising a NSAID and Paracetamol

SUSTAINED-RELEASE PREPARATIONS AND METHOD FOR PRODUCING THE SAME

Chewable formulations

Natural immunostimulant compositions, methods for obtaining the same and pharmaceutical formulations thereof

PHARMACEUTICAL FORMULATIONS CONTAINING IRBESARTAN

Rapidly disintegrating solid oral dosage form

Modified release niacin formulations

Osteoclast Growth Inhibitor, Oral Composition, and Preventive or Therapeutic Agent for Bone Diseases, Containing Liposome-Encapsulated Lactoferrin

Bilayer composition for the sustained release of acetaminophen and tramadol

Oral extended-release composition

PHARMACEUTICAL COMPOSITIONS

Compositions and Methods for Enhancement of Sexual Function

Controlled release tramadol formulations

SUSTAINED-RELEASE PREPARATION

Formulation having accurate dose-dividing function

Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin

Novel nifedipine compositions

SOFT TABLET CONTAINING HIGH MOLECULAR WEIGHT CELLULOSICS

CONTROLLED RELEASE SOLID PREPARATION

Pharmaceutical Sustained Release Compositions and Processes Thereof

SOLID DOSAGE FORMS

Compositions comprising lipophilic active compounds and method for their preparation

Orally disintegrating tablet compositions of lamotrigine

NOVEL CRYSTALLINE FORMS OF CONAZOLES AND METHODS OF MAKING AND USING THE SAME

Tamper resistant dosage forms

Orodispersible domperidone tablets

Dosage Forms Containing A PPI, NSAID And A Buffer

Dosage Forms Containing A PPI, NSAID And A Buffer

Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom

ORALLY ADMINSTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION

Dispersible sustained release pharmaceutical compositions

SOLID PHARMACEUTICAL COMPOSITION FOR ENHANCED DELIVERY OF COENZYME Q-10 AND UBIQUINONES

Thermo-kinetic mixing for pharmaceutical applications

Stabilized milnacipran formulation

Formulations of candesartan

Sustained-release tramadol formulations with 24-hour efficacy

Method for stabilizing phenylephrine

Novel nifedipine compositions

Sustained release composition for oral administration of niacin

Delayed release formulations of 6-mercaptopurine

STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS

PHARMACEUTICAL DOSAGE FORMS COMPRISING A LIPID PHASE

NICOTINIC ACID COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND RELATED METHODS THEREFOR

Fenofibrate compositions

Sustained release formulations of nalbuphine

Solid preparation

Modified release famciclovir pharmaceutical compositions

Vitamin D content uniformity in pharmaceutical dosage forms

Spherical Menthol Particles

Ginger Extract For Inhibiting Human Drug Transporters

Controlled release and taste masking oral pharmaceutical composition

Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water

Complex Formulation Comprising Amlodipine Camsylate And Simvastatin and Method For Preparation Thereof

COMPOSITION COMPRISING COENZYME Q10

PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM

Mouth dissolving pharmaceutical composition and process for preparing the same

Dispersible tablet composition

Abuse resistant drug formulation

Tamper-resistant oral opioid agonist formulations

Tamper-resistant oral opioid agonist formulations

Dispersible Tablets Comprising Deferasirox

Tamper-resistant oral opioid agonist formulations

Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds

Tamper-resistant oral opioid agonist formulations

Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine

Ginger Fraction For Inhibiting Human Cyp Enzymes

Solid Pharmaceutical Dosage Formulation

CONTROLLED RELEASE DOPAMINE AGONIST COMPOSITIONS

Use of copolymers as solubilizers for slightly water-soluble compounds

SOLID PHARMACEUTICAL DOSAGE UNIT FOR ALLEVIATING SYMPTOMS OF RHINORRHEA

Amorphous aripiprazole and process for the preparation thereof

Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof

Composite hydrogel drug delivery systems

ZALTOPROFEN-CONTAINING SUSTAINED RELEASE TABLET AND PROCESS FOR THE PREPARATION THEREOF

Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof

Stable Granulates Containing S-adenosylmethionine and Process for Preparation Thereof

Extended Release Pharmaceutical Composition of Metformin and a Process for Producing It

Novel Process and Formulations

Bioadhesive Rate-Controlled Oral Dosage Formulations

Pharmaceutical Composition

PROCESS FOR PREPARING PRAMIPEXOLE DIHYDROCHLORIDE TABLETS

Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles

Pharmaceutical Active-Ingredient-Containing Formulation with Coating

Nanoparticulate anticonvulsant and immunosuppressive compositions

Combinations of statins and anti-obesity agent

Orodispersible tablets of bitter active principles

Controlled Release Formulation

Minocycline oral dosage forms for the treatment of acne

Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family

Tablets with Improved Dissolution Profile

Stable Pharmaceutical Compositions Comprising a Pyrimidine - Sulfamide

Pharmaceutical Compositions Comprising I Matinib and a Release Retardant

Pharmaceutical composition of quetiapine fumarate

METHOD FOR PREPARATION OF PHARMACEUTICAL COMPOSITION HAVING IMPROVED DISINTEGRATABILITY AND PHARMACEUTICAL COMPOSITION MANUFACTURED BY SAME METHOD

Rapidly disintegrating solid oral dosage form

Formulations of Pyridoxal-5'-Phosphate and Methods of Preparation

Pharmaceutical Preparation Containing Gabapentin

SOLID PHARMACEUTICAL FORMULATIONS OF A HOMOGENEOUS DISPERSION OF ACTIVE PRINCIPLES HAVING pH-DEPENDENT SOLUBILITY

Use of Polymer Mixtures For the Production of Coated Pharmaceutical Formulations and Pharmaceutical Formulation With Mixed Polymeric Coating

Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

PHARMACEUTICAL COMPOSITIONS COMPRISING MEMANTINE

Solid composites of a calcium receptor-active compound

SOLID PHARMACEUTICAL DOSAGE FORMULATIONS

Controlled release dosage form of tacrolimus

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Particulate comprising a calcium-containing compound and a sugar alcohol

Dosage forms for administering combinations of drugs

Pharmaceutical Formulations

Sustained release L-arginine formulations and methods of manufacture and use

GRANISETRON COMPOSITIONS

DIPHOSPHONIC ACID PHARMACEUTICAL COMPOSITIONS

Nanoparticulate fibrate formulations

PHARMACEUTICAL DOSAGE FORMS OF OXCARBAZEPINE

Opioid dosage forms having dose proportional steady state Cand AUC and less than dose proportional single dose C

Tablets comprising a biologically active substance and an excipient containing calcium carbonate

Controlled release nanoparticulate compositions

Novel modified release formulation

Stable pharmaceutical composition containing desloratadine

DPP IV INHIBITOR FORMULATIONS

Multiple Unit Oral Sustained Release Preparation and Production Method Thereof

CONTROLLED RELEASE COLOR STABLE PHARMACEUTICAL DOSAGE FORM OF HMG-COA REDUCTASE INHIBITORS, FREE OF ALKALIZING OR BUFFERING AGENTS

Solid Pharmaceutical Composition Comprising Valsartan

Quick Dissolve Medicament and Method of Manufacturing

Nanoparticulate fibrate formulations

Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof

Topiramate compositions and methods of enhancing its bioavailability

Robust sustained release formulations

Robust sustained release formulations of oxymorphone and methods of use thereof

NOVEL CONTROLLED RELEASE FORMULATIONS OF DIVALPROEX SODIUM

MULTI-CORE DOSAGE FORM HAVING TRANSPARENT OUTER COATING

Dosage forms for tamper prone therapeutic agents

Controlled release formulations

Preparation and administration form comprising an acid-labile active compound

Process for preparing fenofibrate compositions

Fenofibrate compositions

Pharmaceutical Compositions

STABLE TABLET DOSAGE FORMS OF PROTON PUMP INHIBITORS

Acetaminophen pharmaceutical compositions

Pharmaceutical Composition and Galenic Form Corresponding to Rapid Oral Disintegration and Method for Production of Said Composition

STABILIZED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING AN AMG-COA REDUCTASE INHIBITOR

Pharmaceutical Compositions and Methods of Using Same

Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors

BICALUTAMIDE COMPOSITIONS

Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia

ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT

Formulation and process for drug loaded cores

Extended release tablet formulations of flibanserin and method for manufacturing the same

Direct Compression Formulation And Process

Sustained-release bupropion and bupropion/mecamylamine tablets

SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

Controlled-release pharmaceutical tablets

Process for the Preparation of a Solid, Orally Administrable Pharmaceutical Composition

Amorphous aripiprazole and process for the preparation thereof

Composition and method of treating a sore throat

Rapidly disintegrating tablet containing polyvinyl alcohol

Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof

Nanoparticulate fibrate formulations

Particulates

Extended Release Pharmaceutical Composition of Celecoxib

Solid Oral Dosage Form Containing an Enhancer

Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride

LOW DOSE TABLETS OF OPIOID ANALGESICS AND PREPARATION PROCESS

Sustained release formulations of opioid and nonopioid analgesics

METHOD OF TREATING METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES

Ezetimibe compositions

Formulation and process for the preparation of modafinil

Method for treating minor aphthous ulcers

Composition and use